Marketing-authorisation holder · United States
Hetero Labs Ltd V
9 medicines in 1 country, as authorisation holder.
Loading your page…
Loading your page…
Marketing-authorisation holder · United States
9 medicines in 1 country, as authorisation holder.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
9 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| AVANAFIL100mg | 200mg | 50mg · Tablet | Avanafil | United States | Marketed | 2024 |
| ELTROMBOPAG OLAMINE12.5mg acid | 25mg acid | 50mg acid | 75mg acid · Tablet | Eltrombopag | United States | Marketed | 2025 |
| LOPERAMIDE HYDROCHLORIDE AND SIMETHICONE2mg; 125mg · Tablet | Loperamide, Dimethicone | United States | Marketed | 2006 |
| MOXIFLOXACIN HYDROCHLORIDE400mg base · Tablet | Moxifloxacin | United States | Marketed | 2014 |
| MYCOPHENOLATE MOFETIL500mg · Tablet | Mycophenolate mofetil | United States | Marketed | 2008 |
| OSPEMIFENE60mg · Tablet | Ospemifene | United States | Not marketed | 2024 |
| SODIUM PICOSULFATE, MAGNESIUM OXIDE AND ANHYDROUS CITRIC ACID12gm/packet; 3.5gm/packet; 10mg/packet · For solution | Citric acid, Magnesium oxide, Picosulfate | United States | Marketed | 2022 |
| ABACAVIR; LAMIVUDINE60mg; 30mg · Tablet | Abacavir, Lamivudine | United States | tentative | 2015 |
| NILOTINIB HYDROCHLORIDE DIHYDRATE150mg · Capsule | Nilotinib | United States | tentative | 2025 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 9 | 7 | 2 | CompaniesAll medicines |
The active substances in most of its medicines.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Report an error or request removalCorrections from the company itself are welcome.
Other companies in the same group.
Ranked by their number of medicines.